05
Pharmaceutical formulations and preparations to treat acute
and chronic health conditions related to gastrointestinal,
inflammatory, metabolic, endocrine, immunological,
musculoskeletal, cardiovascular, cardiopulmonary,
genitourinary, oncological, hepatological, respiratory,
neurological, psychiatric, dermatological, and viral
diseases and disorders; pharmaceutical compositions in
liquid form, namely, liquid compositions containing protease
inhibitors, to treat health conditions, diseases, and
disorders related to the gastrointestinal tract,
gastrointestinal permeability, the gastrointestinal
epithelial barrier, gastrointestinal inflammation, the
gastrointestinal immune system, the microbiome, and the
gut-brain axis; pharmaceutical formulations and preparations
to treat or prevent surgical complications and postsurgical
complications; pharmaceutical formulations and preparations
to treat or prevent shock, namely, acute shock, cardiogenic
shock, septic shock, hemorrhagic shock, and shock associated
with hypoperfusion; pharmaceutical formulations and
preparations to treat or prevent gastrointestinal
dysfunction, gastrointestinal tract injuries, ileus, and
adhesions; pharmaceutical formulations and preparations to
accelerate the time to return of bowel function in patients
undergoing abdominal surgery; pharmaceutical formulations to
reduce the formation of adhesions following abdominal or
pelvic surgery; pharmaceutical formulations and preparations
to treat or prevent multiorgan failure; pharmaceutical
formulations and preparations to treat or prevent health
conditions, diseases, and disorders related to intestinal
permeability, the microbiome, and the gut-brain axis
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen